Engineered microenvironments provide new insights into ovarian and prostate cancer progression and drug responses
- PMID: 24969478
- DOI: 10.1016/j.addr.2014.06.001
Engineered microenvironments provide new insights into ovarian and prostate cancer progression and drug responses
Abstract
Tissue engineering technologies, which have originally been designed to reconstitute damaged tissue structure and function, can mimic not only tissue regeneration processes but also cancer development and progression. Bioengineered approaches allow cell biologists to develop sophisticated experimentally and physiologically relevant cancer models to recapitulate the complexity of the disease seen in patients. Tissue engineering tools enable three-dimensionality based on the design of biomaterials and scaffolds that re-create the geometry, chemistry, function and signalling milieu of the native tumour microenvironment. Three-dimensional (3D) microenvironments, including cell-derived matrices, biomaterial-based cell culture models and integrated co-cultures with engineered stromal components, are powerful tools to study dynamic processes like proteolytic functions associated with cancer progression, metastasis and resistance to therapeutics. In this review, we discuss how biomimetic strategies can reproduce a humanised niche for human cancer cells, such as peritoneal or bone-like microenvironments, addressing specific aspects of ovarian and prostate cancer progression and therapy response.
Keywords: 3D culture models; Bone metastasis; Humanised; Intraperitoneal metastasis; Preclinical drug testing; Tissue engineering.
Copyright © 2014 Elsevier B.V. All rights reserved.
Similar articles
-
Tissue-engineered 3D models for elucidating primary and metastatic bone cancer progression.Acta Biomater. 2019 Nov;99:18-32. doi: 10.1016/j.actbio.2019.08.020. Epub 2019 Aug 13. Acta Biomater. 2019. PMID: 31419564 Free PMC article. Review.
-
Microfluidic culture models to study the hydrodynamics of tumor progression and therapeutic response.Biotechnol Bioeng. 2013 Aug;110(8):2063-72. doi: 10.1002/bit.24944. Epub 2013 Jun 15. Biotechnol Bioeng. 2013. PMID: 23616255 Review.
-
Growth of confined cancer spheroids: a combined experimental and mathematical modelling approach.Integr Biol (Camb). 2013 Mar;5(3):597-605. doi: 10.1039/c3ib20252f. Integr Biol (Camb). 2013. PMID: 23388834
-
Using high throughput microtissue culture to study the difference in prostate cancer cell behavior and drug response in 2D and 3D co-cultures.BMC Cancer. 2018 May 24;18(1):592. doi: 10.1186/s12885-018-4473-8. BMC Cancer. 2018. PMID: 29793440 Free PMC article.
-
Species-specific homing mechanisms of human prostate cancer metastasis in tissue engineered bone.Biomaterials. 2014 Apr;35(13):4108-15. doi: 10.1016/j.biomaterials.2014.01.062. Epub 2014 Feb 16. Biomaterials. 2014. PMID: 24534484
Cited by
-
The distribution of the apparent diffusion coefficient as an indicator of the response to chemotherapeutics in ovarian tumour xenografts.Sci Rep. 2017 Feb 21;7:42905. doi: 10.1038/srep42905. Sci Rep. 2017. PMID: 28220831 Free PMC article.
-
Designer Self-Assembling Peptide Hydrogels to Engineer 3D Cell Microenvironments for Cell Constructs Formation and Precise Oncology Remodeling in Ovarian Cancer.Adv Sci (Weinh). 2020 Mar 20;7(9):1903718. doi: 10.1002/advs.201903718. eCollection 2020 May. Adv Sci (Weinh). 2020. PMID: 32382486 Free PMC article. Review.
-
Functionalization, preparation and use of cell-laden gelatin methacryloyl-based hydrogels as modular tissue culture platforms.Nat Protoc. 2016 Apr;11(4):727-46. doi: 10.1038/nprot.2016.037. Epub 2016 Mar 17. Nat Protoc. 2016. PMID: 26985572
-
High EMT Signature Score of Invasive Non-Small Cell Lung Cancer (NSCLC) Cells Correlates with NFκB Driven Colony-Stimulating Factor 2 (CSF2/GM-CSF) Secretion by Neighboring Stromal Fibroblasts.PLoS One. 2015 Apr 28;10(4):e0124283. doi: 10.1371/journal.pone.0124283. eCollection 2015. PLoS One. 2015. PMID: 25919140 Free PMC article.
-
Cell-Based Methods for Determination of Efficacy for Candidate Therapeutics in the Clinical Management of Cancer.Diseases. 2018 Sep 22;6(4):85. doi: 10.3390/diseases6040085. Diseases. 2018. PMID: 30249005 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical